Targeted delivery to the lower regions of the lung is necessary for the treatment of parenchymal lung injury and disease but is challenging. Here, the authors develop an mRNA delivery platform to treat acute lung injury in mice and demonstrate that it can reach the lower regions of the lung.
- Jaclynn A. Meshanni
- Emily R. Stevenson
- Elena N. Atochina-Vasserman
